Scientia Clinical Research

Randwick, New South Wales 2148

12 studies enrolling now · 15 studies all time

What they study most

Acral Melanoma, Advanced Breast Cancer, Advanced Lung Cancer, Advanced Malignancies, Advanced Solid Tumor, Advanced Solid Tumors, Advanced or Metastatic Solid Tumors, Basal Cell Carcinoma, Bladder Cancer, Cancer With A High Tumor Mutational Burden, Cervical Cancer, Cervical Cancers

Studies at this site

• A Study of DM002 in Patients With Advanced Solid Tumors — Recruiting now
• A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors. — Recruiting now
• First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors — Recruiting now
• Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer — Recruiting now
• ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours — Recruiting now
• Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC) — Recruiting now
• SNV1521 in Participants With Advanced Solid Tumors — Recruiting now
• Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors — Recruiting now
• Study in Advanced Solid Tumor Patients — Recruiting now
• SNV4818 in Participants With Advanced Solid Tumors — Recruiting now
• A Beta-only IL-2 ImmunoTherapY Study — Recruiting now
• DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors — Recruiting now
• S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP — Running, not enrolling
• Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors — Running, not enrolling
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies — Completed